OVID
Ovid Therapeutics Inc
2.40$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Ovid Therapeutics Inc (OVID) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10 | -12 | -17 | -14 | -15 | -10 | -10 | -4.8 | -13 | -10 | -14 | -18 | -55 | |
| 0.4 | 0.4 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 1.6 | 1.8 | 2.0 | 1.7 | 1.3 | 1.3 | 1.3 | 1.2 | 1.1 | 1.2 | 1.0 | 1.4 | 4.8 | |
| 0.0 | 3.7 | -1.7 | 4.2 | -1.7 | -0.9 | -1.3 | -1.2 | -1.7 | 0.1 | 2.3 | -2.1 | -1.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -4.4 | -49 | 20 | 13 | 0.3 | 21 | 5.1 | 12 | 5.1 | -72 | 6.0 | -87 | -148 | |
| – | -15,449 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.2 | 30 | 0.2 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 75 | 89 | 22 | 186 | |
| -14 | -30 | 3.7 | -1.1 | -15 | 11 | -5.2 | 7.3 | -7.8 | -7.5 | 81 | -83 | -17 | |
| -10 | -12 | -17 | -14 | -15 | -10 | -10 | -4.8 | -13 | -10 | -14 | -18 | -55 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.